Jim Cramer Answered Questions About 13 Stocks: Eli Lilly, Meta, and More
A couple of weeks ago, Jack Dorsey, CEO of Block, the old Square, did the unthinkable, saying he would cut his workforce almost in half from 10,000 people to just 6,000.
Recursion Pharmaceuticals Inc. (RXRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 37,316,856 | $152,625,940 | +12% | 1.01% |
| 2. | SOFTBANK GROUP CORP Masayoshi Son | 13,636,515 | $55,773,346 | -8% | 0.36% |
| 3. | MIC Capital Partners Mubadala Investment | 9,644,032 | $39,444,095 | 8.94% | |
| 4. | Citadel Investment Group Ken Griffin | 4,229,999 | $17,300,696 | +214% | 0% |
| 5. | 1,978,800 | $8,093,292 | +2% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.82 | 66,822 | $522,354.26 | 12,985,927 | 2023-03-02 | Filing | |
| $7.94 | 48,867 | $388,082.17 | 12,919,105 | 2023-03-01 | Filing | |
| $7.97 | 815 | $6,495.55 | 12,870,238 | 2023-02-28 | Filing | |
| $7.69 | 52,500 | $403,725.00 | 12,869,423 | 2023-02-27 | Filing | |
| $7.64 | 109,118 | $833,552.40 | 12,816,923 | 2023-02-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.39 | 7,956 | $26,970.84 | 1,180,318 | 2026-03-17 | Filing | |
| $3.35 | 28,298 | $94,659.64 | 2,262,085 | 2026-03-09 | Filing | |
| $3.46 | 170,000 | $588,200.00 | 6,259,863 | 2026-03-03 | Filing | |
| $3.46 | 40,000 | $138,400.00 | 906,556 | 2026-02-19 | Filing | |
| $3.08 | 13,426 | $41,352.08 | 1,195,349 | 2026-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 47,187,759 | $192,997,934 | 0% | |
| 2. | 38,866,779 | $158,965,127 | 0% | |
| 3. | 25,333,888 | $103,615,602 | 0% | |
| 4. | 23,774,972 | $97,239,635 | 0.08% | |
| 5. | 10,934,252 | $44,731,450 | 0% |
News See All
What Makes Recursion Pharmaceuticals (RXRX) So Attractive
On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million compared to the consensus estimates of $24.6 million.
11 Most Popular AI Penny Stocks to Buy Now
The need for the adoption of Artificial Intelligence (AI) is becoming increasingly pivotal for businesses to elevate their operations.
BoFA Lowers PT on Recursion Pharmaceuticals (RXRX), Keeps a Hold Rating
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Low Risk Penny Stocks to Buy Now. On February 27, Bank of America Securities reiterated a Hold rating on Recursion Pharmaceuticals, Inc.
10 Low Risk Penny Stocks to Buy Now
On March 4, Eddie Ghabour from Key Advisors Wealth Management appeared on a Schwab Network interview to discuss the buying opportunities in the market.
Recursion Pharmaceuticals (RXRX) Hits Clinical Milestones as 2025 Revenue Grows to $74.7M
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most promising penny stocks under $5 to buy.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2025 Earnings Call Transcript
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2025 Earnings Call Transcript February 25, 2026Recursion Pharmaceuticals, Inc. beats earnings expectations.
13 Most Promising Penny Stocks Under $5 to Buy
On February 23, Pierre Ouimet, head investment strategist at UBS Canada, joined BNN Bloomberg to discuss the markets and provide a spotlight on undervalued sectors.
Recursion Pharmaceuticals, Inc. (RXRX) Advances AI Drug Discovery Amid Market Shifts
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the AI stocks that will go to the moon. On February 18, Recursion Pharmaceuticals, Inc.
11 AI Stocks That Will Go to the Moon
The artificial intelligence trade is alive and well, even as valuation concerns continue to send shockwaves on Wall Street.
Hedge Fund Resource Center